GI
RNAM

GAMCO Investors’s Avidity Biosciences RNAM Stock Holding History

GAMCO Investors’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,500
Closed -$252K – 1058
2025
Q4 		$252K Buy
+3,500
New +$226K ﹤0.01% 959

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

GAMCO Investors's RNAM Position: Q1 2026 in Review

GAMCO Investors sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 3,500 shares — an estimated $252K sold.

GAMCO Investors first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $252K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • GAMCO Investors reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • GAMCO Investors sold 3,500 Avidity Biosciences shares in Q1 2026, an estimated $252K.
  • GAMCO Investors first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • GAMCO Investors's Avidity Biosciences position peaked at $252K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on GAMCO Investors's 13F filing for Q1 2026, filed 14 May 2026.